The checkpoint inhibitor pembrolizumab (Keytruda) offers patients with advanced head and neck cancers longer survival time, according to researchers led by the Yale Cancer Center
Researchers at the Rutgers School of Public Health have identified factors that may put people who responded to the 9/11 terrorist attacks at the World
Cigarette smoke reprograms the cells that surround head and neck squamous cell carcinoma (HNSCC) cells and drives the cancer’s aggressiveness, according to researchers at Thomas
The Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology now recommend photobiomodulation or low-dose light therapy to prevent oral mucositis
Painful sores in the mouth and throat are among the most common adverse side effects caused by radiation therapy for most cancers of the head
Regular use of aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) may help some patients with head and neck cancer survive the disease, according researchers at
While head and neck cancer patients often receive pain medications during recovery from surgery, the use of opioids could be a gateway to misuse or
Head and neck cancer is the sixth most common cancer in the world, with about 600,000 new cases each year and nearly half of all
The National Institute of Dental and Craniofacial Research (NIDCR) has announced 4 awards totaling approximately $1 million each per year for up to 8 years,
The human papillomavirus (HPV) vaccine may reduce the rate of oral HPV infections in young adults by as much as 88%, reports the University of
Oral cancer awareness is promoted each April. Organizations such as the Head and Neck Cancer Alliance and the Oral Cancer Foundation are working to enhance
The National Cancer Institute has awarded SuviCa Inc. approximately $1.5 million to continue work on new treatments for head and neck cancer. For example, the
